Unknown

Dataset Information

0

Kynurenine 3-monooxygenase upregulates pluripotent genes through ?-catenin and promotes triple-negative breast cancer progression.


ABSTRACT: BACKGROUND:Triple-negative breast cancer (TNBC) is aggressive and has a poor prognosis. Kynurenine 3-monooxygenase (KMO), a crucial kynurenine metabolic enzyme, is involved in inflammation, immune response and tumorigenesis. We aimed to study the role of KMO in TNBC. METHODS:KMO alteration and expression data from public databases were analyzed. KMO expression levels in TNBC samples were analyzed using immunohistochemistry. Knockdown of KMO in TNBC cells was achieved by RNAi and CRISPR/Cas9. KMO functions were examined by MTT, colony-forming, transwell migration/invasion, and mammosphere assays. The molecular events were analyzed by cDNA microarrays, Western blot, quantitative real-time PCR and luciferase reporter assays. Tumor growth and metastasis were detected by orthotopic xenograft and tail vein metastasis mouse models, respectively. FINDINGS:KMO was amplified and associated with worse survival in breast cancer patients. KMO expression levels were higher in TNBC tumors compared to adjacent normal mammary tissues. In vitro ectopic KMO expression increased cell growth, colony and mammosphere formation, migration, invasion as well as mesenchymal marker expression levels in TNBC cells. In addition, KMO increased pluripotent gene expression levels and promoter activities in vitro. Mechanistically, KMO was associated with ?-catenin and prevented ?-catenin degradation, thereby enhancing the transcription of pluripotent genes. KMO knockdown suppressed tumor growth and the expression levels of ?-catenin, CD44 and Nanog. Furthermore, mutant KMO (known with suppressed enzymatic activity) could still promote TNBC cell migration/invasion. Importantly, mice bearing CRISPR KMO-knockdown TNBC tumors showed decreased lung metastasis and prolonged survival. INTERPRETATION:KMO regulates pluripotent genes via ?-catenin and plays an oncogenic role in TNBC progression.

SUBMITTER: Huang TT 

PROVIDER: S-EPMC7191260 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Kynurenine 3-monooxygenase upregulates pluripotent genes through β-catenin and promotes triple-negative breast cancer progression.

Huang Tzu-Ting TT   Tseng Ling-Ming LM   Chen Ji-Lin JL   Chu Pei-Yi PY   Lee Chia-Han CH   Huang Chun-Teng CT   Wang Wan-Lun WL   Lau Ka-Yi KY   Tseng Mei-Fang MF   Chang Yuan-Ya YY   Chiang Tzu-Yi TY   Ueng Yune-Fang YF   Lee Hsin-Chen HC   Dai Ming-Shen MS   Liu Chun-Yu CY  

EBioMedicine 20200401


<h4>Background</h4>Triple-negative breast cancer (TNBC) is aggressive and has a poor prognosis. Kynurenine 3-monooxygenase (KMO), a crucial kynurenine metabolic enzyme, is involved in inflammation, immune response and tumorigenesis. We aimed to study the role of KMO in TNBC.<h4>Methods</h4>KMO alteration and expression data from public databases were analyzed. KMO expression levels in TNBC samples were analyzed using immunohistochemistry. Knockdown of KMO in TNBC cells was achieved by RNAi and C  ...[more]

Similar Datasets

2020-05-06 | GSE145661 | GEO
| PRJNA607845 | ENA
| S-EPMC8204454 | biostudies-literature
| S-EPMC5832424 | biostudies-literature
| S-EPMC7260014 | biostudies-literature
| S-EPMC9132940 | biostudies-literature
| S-EPMC7244539 | biostudies-literature
| S-EPMC6682511 | biostudies-literature
| S-EPMC8380247 | biostudies-literature
| S-EPMC9282371 | biostudies-literature